16 March 2023 : Case report
A 64-Year-Old Man Hospitalized for COVID-19 Pneumonia and Treated with Tocilizumab Who Developed Chronic Cavitary Pulmonary Aspergillosis
Unusual or unexpected effect of treatment, Adverse events of drug therapy , Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
DOI: 10.12659/AJCR.938359
Am J Case Rep 2023; 24:e938359
Related articles
Coming soon...
SARS-CoV-2/COVID-19
22 February 2023 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.938732
22 February 2023 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.938761
16 March 2023 : Case report 
Am J Case Rep 2023; 24:e938359
01 March 2023 : Case report
Am J Case Rep 2023; 24:e937955
In Press
20 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938650
17 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939411
17 Mar 2023 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.939474
16 Mar 2023 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.938752
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
06 Dec 2021 : Case report 
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347